Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
214.9 USD | +1.34% | +0.84% | +2.05% |
May. 24 | Cattle on Feed Report Shows Higher-Than-Expected Marketings | DJ |
May. 24 | LIVESTOCK-CME live cattle mixed, feeder cattle lower ahead of holiday weekend | RE |
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- This company will be of major interest to investors in search of a high dividend stock.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- With a 2024 P/E ratio at 22.46 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- The company appears highly valued given the size of its balance sheet.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Financial & Commodity Market Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+2.05% | 77.39B | B | ||
+23.51% | 23.92B | C+ | ||
+25.95% | 12.26B | C+ | ||
+0.24% | 8.13B | B- | ||
+26.77% | 7.58B | C+ | ||
-6.47% | 2.83B | C+ | ||
+17.39% | 2.31B | C | ||
-6.10% | 1.69B | C | ||
+24.19% | 1.4B | - | ||
+90.57% | 1.38B | - | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CME Stock
- Ratings CME Group Inc.